Cargando…
Prognosis and prediction of antibiotic benefit in adults with clinically diagnosed acute rhinosinusitis: an individual participant data meta-analysis
BACKGROUND: A previous individual participant data meta-analysis (IPD-MA) of antibiotics for adults with clinically diagnosed acute rhinosinusitis (ARS) showed a marginal overall effect of antibiotics, but was unable to identify patients that are most likely to benefit from antibiotics when applying...
Autores principales: | Hoogland, Jeroen, Takada, Toshihiko, van Smeden, Maarten, Rovers, Maroeska M., de Sutter, An I., Merenstein, Daniel, Kaiser, Laurent, Liira, Helena, Little, Paul, Bucher, Heiner C., Moons, Karel G. M., Reitsma, Johannes B., Venekamp, Roderick P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478354/ https://www.ncbi.nlm.nih.gov/pubmed/37667327 http://dx.doi.org/10.1186/s41512-023-00154-0 |
Ejemplares similares
-
Identifying adults with acute rhinosinusitis in primary care that benefit most from antibiotics: protocol of an individual patient data meta-analysis using multivariable risk prediction modelling
por: Venekamp, Roderick P, et al.
Publicado: (2021) -
Diagnostic prediction models for CT-confirmed and bacterial rhinosinusitis in primary care: individual participant data meta-analysis
por: Takada, Toshihiko, et al.
Publicado: (2022) -
Accuracy of signs, symptoms and blood tests for diagnosing acute bacterial rhinosinusitis and CT-confirmed acute rhinosinusitis in adults: protocol of an individual patient data meta-analysis
por: Venekamp, Roderick, et al.
Publicado: (2020) -
Individual Participant Data (IPD) Meta-analyses of Diagnostic and Prognostic Modeling Studies: Guidance on Their Use
por: Debray, Thomas P. A., et al.
Publicado: (2015) -
Predicting personalised absolute treatment effects in individual participant data meta‐analysis: An introduction to splines
por: Belias, Michail, et al.
Publicado: (2022)